GRN mutation carriers typically present with clinical phenotypes of behavioral variant FTD or primary progressive aphasia in the fifth or sixth decade of life, and universally exhibit a progressive course, with average survival of 6years from symptom onset.2 This evidence concerns the gene GRN and frontotemporal dementia.